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Abstract. Schistosomiasis is a major public health problem in Madagascar. The WHO recommends preventive
chemotherapy by mass drug administration (MDA) with praziquantel as the primary approach to control Schistosoma
mansoni–related morbidity in endemic populations, alongside complementary interventions such as health education.
The impact of annual MDA and health education programs was assessed in the hard-to-reach Marolambo district of
eastern Madagascar, an area endemic for S. mansoni. Repeated cross-sectional studies undertaken 2015–2019 ex-
amined between 300 and 381 school-aged children (aged 5–14 years) annually. The prevalence and infection intensity of
S. mansoni were assessed by urine-circulating cathodic antigen (CCA) dipsticks and coproscopy using Kato–Katz (KK)
methodologies. After four rounds of annual MDA, a reduction in S. mansoni prevalence was seen in CCA (93.9% in year
1–87.7% in year 5; P = 0.007) and KK (73.9% in year 1–59.4% in year 5; P < 0.0001). The prevalence of heavy-intensity
infections roughly halved from23.7%to10.1%(P<0.0001), and themean intensity of infection fell by55.0% (480.2–216.3
eggs per gram of feces). A malacological survey found Biomphalaria pfeifferi snail intermediate hosts in multiple water
contact sites including rice paddies, streams, and Nosivolo River. Despite reductions in infection prevalence and in-
tensity, schistosomiasis still poses a significant public health challenge in Marolambo district. Twice yearly MDA cycles
and/or community-wide MDA are suggested to better reduce infections. Expanding health education; improving stan-
dards of water, sanitation, and hygiene; and attention on snail-related control will also be important, especially in rice
paddy irrigated areas.
INTRODUCTION
Schistosomiasis is a neglected tropical disease (NTD),
which affects 290 million people worldwide across 78 en-
demic countries.1,2 The disease costsmore than 200,000 lives
and between 1.1 and 3.2 million disability-adjusted life years
annually, predominantly in sub-Saharan Africa.3 In Mada-
gascar, 107 of 114 districts are endemic with either or both
forms of schistosomiasis.4 Schistosoma haematobium is the
causative species of urogenital schistosomiasis and inflicts
disease in northern and western districts of Madagascar,
whereasS.mansoni, which causes intestinal schistosomiasis,
dominates in southern and eastern districts.5 This geo-
graphical distribution tracks each trematode’s obligatory in-
termediate snail hosts, Bulinus and Biomphalaria, respectively.6
Infection by either S. mansoni or S. haematobium can lead
to significant illness and disability including anemia, under-
nutrition, reduced exercise tolerance, stunting, wasting, and
cognitive impairment and educational loss.2,7 Chronic schis-
tosomiasis can result in potentially fatal conditions such as
liver fibrosis due to S. mansoni in hepatosplenic schistoso-
miasis, and bladder cancer due to S. haematobium with
chronic urogenital schistosomiasis.8 Over time, the severity of
disease correlates with elevated infection intensity, which can
be determined by counting and calculating the eggs per gram
(EPG) as visualizedby coproscopyor uroscopy.9 Studies have
demonstrated that through treatment with praziquantel, some
downstream conditions of intestinal schistosomiasis, in-
cluding liver fibrosis, can be reversed, alongside decline in the
fecal EPG.10–12
In areas with high endemicity, characterized by a > 50%
prevalence of schistosomiasis among school-aged children
(SAC), the WHO advises preventive chemotherapy by annual
massdrug administration (MDA)with praziquantel to the entire
community.13 The aim is for more than 75% of SAC at risk of
schistosomiasis to receive regular MDA with PZQ.14 In 2017,
global PZQ coverage for SAC in need of regular treatment was
70.8%, whereas coverage of at-risk adults was 16.8%.15 In
addition to regular MDA, additional supportive interventions
are encouraged to reduce transmission: health education and
improving access to safe water and sanitation.16 The WHO
schistosomiasis strategy strives first for control of disease
morbidity as a public health problem (as defined as a preva-
lence of heavy infection intensities of < 5%) and then for
elimination of schistosomiasis as a public health problem
(heavy infection prevalence < 1% in all sentinel sites).16
Monitoring response to intervention is therefore vital to de-
termine effectiveness and to intensify MDA schedules if
required.17
Marolambo is a hard-to-reach district in the east of Mada-
gascar, and our first investigations identified 94% prevalence
of S. mansoni among SAC and high burden of disease, where
11% of children have ultrasonographic evidence of liver
fibrosis.18,19 To the best of our knowledge, regular monitoring
ofS.mansoni infection amongMalagasy communities has not
been attempted. On identification of the considerable burden
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of infection in this region, the National Control Program de-
livered four rounds of annual MDA between 2015 and 2019.
Since 2017, an adjunct schistosomiasis education program
(SEP)was codevelopedwith the community and introduced in
the local schools by the MADagascar mEdical eXpeditions’
(MADEX) (S. A. Spencer, et al., unpublished data). The study
we report here comparesS.mansoni infection prevalence and
intensity of infection over a five-year period (2015–2019) with
observations on Biomphalaria, in the Marolambo district,
Madagascar, through four repeated cross-sectional studies.
MATERIALS AND METHODS
Study area and population. Marolambo is a district in the
east ofMadagascar, with an estimated population of 215,000.
The district is remote with a single access road in seasonal
disrepair and no roads between villages. Six villages (Mar-
olambo, Ampasimbola, Ambohitelo, Marofatsy, Vohidamba,
and Betampona) were purposively selected for their accessi-
bility by foot and links with community collaborators.
Communities in the Marolambo district rely on environ-
mental water from the Nosivolo River for drinking, cooking,
washing, and transport. Historically, there have been addi-
tional gravitational water supply systems providing water
through a series of pipes from streams to the villages. How-
ever, these are prone to damage, leaving very few (if any) in the
villages today. Between these six villages, therewere a total of
27 gravitational water supplies in 2015, and nine by 2018. It is
common practice for children to assist their families in fetch-
ing domestic water from the Nosivolo River or surrounding
streams.
Before 2015, there had not been an MDA in the Marolambo
district since 2008. Since our identification of endemic in-
fection in the region,19 yearly MDAwith praziquantel has been
delivered to all SAC in the six villages since 2015, and
attempted across the entire Marolambo district since 2018 by
the Madagascar Ministry of Health. Formal SEPs have been
implemented annually since 2017, which help to rectify com-
munity knowledge deficits in understanding of intestinal
schistosomiasis.
Study design. Repeated cross-sectional studies were
carried out in 2015 (baseline/year 1), 2016 (year 2), 2017 (year
3), and2019 (year 5). EachstudywascarriedoutbetweenJune
and July in six villages in the Marolambo district: Marolambo,
Ampasimbola, Ambohitelo, Marofatsy, Vohidamba, and
Betampona (Figure 1).
Each year, schistosomiasis prevalence and infection in-
tensitywere determined during a four- to six-weekMADEX. All
school pupils in each village school (one school per village)
were assigned a unique identification number and then strat-
ified by age, gender, and location. FollowingWHO guidelines,
a minimum of 50 children were then randomly selected from
each school, with approximately equal numbers by age,
gender, and school.13 The same process was repeated each
year of the study.
Three days were spent within each village, each year of the
study, fostering sufficient community engagement. The first
two days each year were spent on research (parasitological
assessment) andeducationmethodology;MDAwasdelivered
after completion of all research methods, on day 3.
Parasitology. Children were provided with a labeled stool
and urine sample container and instructed how to collect stool
and urine. Samples were collected the following day and an-
alyzed by the researchers the same day in the field. Urine
samples were tested for circulating cathodic antigen (CCA)
using a urine-cassette assay (RapidMedical Diagnostic Tests,
Pretoria, South Africa) by trained and experienced techni-
cians. Assays were conducted following the manufacturer’s
instructions and independently analyzed by two technicians.
Circulating cathodic antigen (CCA) results were recorded in
two ways: as a binary outcome of negative or positive, and as
categories (negative [−], trace positive [tr], single positive [+],
double positive [++], or triple positive [+++]) as per previous
studies.20
The Kato–Katz methodology (Vestergaard-Frandsen, Lau-
sanne, Switzerland) was used to identify S. mansoni eggs in
the stool samples.21 Two thick smears of 41.7 mg of feces
were prepared from each sample. The total EPG were calcu-
lated from each slide. Results were recorded as follows: 1)
positive or negative, 2) the mean EPG between the two slides,
and 3) the WHO classification of infection intensity as light
(1–99 EPG),moderate (100–399 EPG), or heavy (³ 400 EPG).16
To ensure quality control, one in every 10 slides were reex-
amined by experienced scientists at the Institut Pasteur de
Madagascar who were blinded to the findings of others. If a
difference was identified, the slide was reexamined, and a
consensusEPGwas reachedand infection intensity assigned.
In year 1, because of a local logistic constraint, no KK mi-
croscopy was performed in Marolambo. In year 4, as national
control program delivered MDA to this population 1 month
before the MADEX surveillance, collected parasitology data
were not included in this analysis.
Malacology In year 5, a freshwater malacological survey
was carried out where medically important freshwater snails
were collected from knownwater contact sites (river, streams,
or rice paddies) in each village (Figure 1). A transect of 10
square meters per water contact site was assessed for the
presence of aquatic snails between the hours of 9:00 and 17:
00. Snailswere collected using ahandheld sieve and identified
by shell morphology at location. All Biomphalaria snails were
then placed in transparent trays and kept in direct sunlight to
encourage shedding of S. mansoni cercariae. The water from
shedding trays was analyzed under light microscopy (×20) to
identify cercariae, allowing snails to be recorded as infected or
uninfected. To determine the species of Biomphalaria, DNA
was extracted from a sample of Biomphalaria using DNeasy
(Qiagen®) at Institut Pasteur de Madagascar. Molecular
analysis of these samples was later conducted at Liverpool
School of Tropical Medicine, whereby Biomphalaria mito-
chondrial cytochrome oxidase subunit 1 (CO1) gene frag-
ments were amplified by PCR and later DNA sequencing
analysis.
Statistical analysis. All results were recorded in the field
with paper and uploaded intoMicrosoft Excel (Redmond,WA)
at a later date. Statistical analyses were performed using
StataCorp 2017 (Stata Statistical Software 15. College Sta-
tion, TX: StataCorp LLC). Chi-squared tests were used to
assess the crude relationships between the prevalence by KK
and CCA with age, year, gender, and location.
Mixed-effects generalized linear models were used to as-
sess the changes in the prevalence of S. mansoni by both KK
and CCA. Tests of departure from linear trend were carried
out. Spearman’s rank correlation coefficient was used to ex-
amine the linear trend between EPG and year. Simple linear
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regression analysis was used to examine the association of
mean EPG by year, adjusted by location, age, and gender.
Results were considered significant if P < 0.05.
Retrospective post hoc sample size calculations were car-
ried out to be able to detect differences in prevalencebyKK for
each village. To detect a difference in the prevalence of 35%
from the baseline prevalence of 74%,22 31 study participants
were required for each village. To account for nonresponse
and for subgroup analyses, this agreedwith our initial target of
50 recruited participants for each village as recommended in
WHO guidelines.13
Consent and permissions. The study was designed with
input from health leaders at both a national and regional level.
Before research, briefings in the Malagasy language (local
dialect) were held with the local leaders, children, and parents
with opportunities for questions and comments. Participation
information sheets and consent forms were translated into
Malagasy in the local dialect and read to parents and children
FIGURE 1. MapofMarolambo,Madagascar, with locations of human–water contact sites infestedwithBiomphalaria snails. This figure appears in
color at www.ajtmh.org.
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and the local community.Children couldprovide assent for the
study by stamping their fingerprint in addition to their parents’
consent.
Ethical approval. Ethical approval was granted by the
University of Manchester Research Ethics Committee and the
Ministère de la Santé Publique de Madagascar. Written con-
sent for participation in the study was obtained from the child
and their parent/guardian. All human data were anonymized.
RESULTS
Between 300 and 381 children were recruited each year of
the study with ³ 93.0% CCA and KK samples to be analyzed
from recruited participants each year (Table 1).
Dynamics of S. mansoni prevalence. The baseline preva-
lence ofS.mansoni by CCAwas 356/379 (93.9%) and 215/291
(73.9%) by KK (Figure 2). By CCA, the prevalence reduced in
year 3 to 259/295 (87.8%;PRadj 0.935 (0.899–0.989),P= 0.007;
Figure2).However, therewasno further reduction inprevalence
by CCA, and in year 5, the prevalence was 321/366 (87.7%).
By KK, there were no prevalence reductions in years 2 or 3.
However, by year 5, the prevalence had fallen to 206/347
(59.4%) (PRadj 0.809 [0.719–0.910], P < 0.0001; Figure 2; see
Supplemental Tables S1–S3 for full list of results from the
generalized linear mixed models).
Therewerenodifferences inprevalencebyeitherCCAorKK
between females and males each year of the study
(Supplemental Tables S1 and S2).
DynamicsofS.mansoni infection intensity.Comparisons
of the changes in prevalence in heavy, moderate, light, and
negative infections through KK analysis demonstrate a
district-wide reduction in the prevalence of heavy infections
and an increase in the proportion of negative infections, with
no significant changes in the prevalence of moderate or light
infections (Figure 3). Specifically, the district prevalence of
heavy infection intensities fell from 69/291 (23.7%) to 35/347
(10.1%; PRadj 0.467 [0.317–0.687], P < 0.0001).
Among infected children, the EPG fell each year (Spear-
man’s rho = −0.21, P < 0.0001). The mean EPG fell by 55.0%,
from 480.2 at baseline to 216.3 in year 5 (Figure 2). The linear
regression analysis estimated a reduction in the district-wide
mean EPG of −58.8 (−82.9, −34.6; P < 0.0001; Table 2) fol-
lowing each round of MDA in this study population.
Changes in prevalence and infection intensity stratified
by village.When stratified at the level of the village, therewere
significant reductions in prevalence by KK in Ambohitelo
(PRadj 0.665 [0.484–0.912], P = 0.012) and Marofatsy (PRadj
0.461 [0.250–0.853], but noother location (P=0.014; Figure 4).
When additionally stratified by age, no changes in KK preva-
lence were observed in any village; however, by CCA, there
was a reduction in prevalence among 9- to 12-year-olds in
Ambohitelo (Supplemental Figure S1).
Through comparisons of the mean EPG from year 5 to
baseline, significant changes were identified in two villages:
Ambohitelo (relative reduction of 78.6% [from 363.0 in year
1–77.8 in year 5; Padj = 0.002; Table 2]) and Betampona (rel-
ative reduction of 43.3% [from 503.4 in year 1–285.2 in year 5;
Padj = 0.042]). Linear regression analyses estimated annual
reductions in the mean EPG in children living in only Ambo-
hitelo and Ampasimbola villages (Figure 5).
The scatterplot analysis in Figure 5 demonstrates that there
are many outliers with extremely high infection intensities in
years 1–3, with a narrowing of EPG data points across the
study period, particularly in Ampasimbola, Ambohitelo, Mar-
ofatsy, and Vohidamba. However, in year 5, most of the out-
liers with extremely high infection intensities originated from
either Betampona or Marolambo (Figure 5).
There were no differences in mean EPG between age-
groups (Supplemental Figure S2). When additionally stratified
by village, the only reduction in mean EPG was observed
among 9- to 12-year-olds in Ambohitelo.
Mass drug administration coverage. In year 2, 167/262
(63.7%) children attended MDA; in year 3, 315/346 (91.0%)
children attended MDA; and in year 4, 222/264 (84.1%) chil-
dren attended MDA.
Observations on malacology. Biomphalaria pfeifferi, the
intermediate aquatic snail host for S. mansoni, was identified
inwater contact sites in each village, in theNosivolo River, rice
paddies, and streams (Figure 1). Shedding of S. mansoni
cercariae was seen from 16/117 (13.7%) of B. pfeifferi col-
lected. All B. pfeifferi infected with S. mansoni were found in
Betampona village.
TABLE 1
Study participant characteristics and number recruited each year of the study
Baseline/year 1, 2015 Year 2, 2016 Year 3, 2017 Year 5, 2019
n (%) n (%) n (%) n (%)
Age-group (years)
5–8 134 (35.2) 108 (36.0) 120 (40.0) 156 (41.8)
9–12 161 (42.3) 128 (42.7) 120 (40.0) 150 (40.2)
13–14 86 (22.6) 64 (21.3) 60 (20.0) 67 (18.0)
Gender
Female 188 (49.3) 153 (51.0) 149 (49.7) 189 (50.7)
Male 193 (50.7) 147 (49.0) 151 (50.3) 184 (49.3)
Village
Marolambo 84 (22.0) 50 (16.7) 50 (16.7) 119 (31.9)
Ampasimbola 67 (17.6) 50 (16.7) 50 (16.7) 18 (4.8)
Ambohitelo 69 (18.1) 50 (16.7) 50 (16.7) 59 (15.8)
Marofatsy 57 (15.0) 50 (16.7) 50 (16.7) 23 (6.2)
Vohidamba 53 (13.9) 50 (16.7) 50 (16.7) 22 (5.9)
Betampona 51 (13.4) 50 (16.7) 50 (16.7) 132 (35.4)
Total no. of participants 381 300 300 373
No. eligible CCA samples 379/381 (99.5) 298/300 (99.3) 295/300 (98.3) 366/373 (98.1)
No. eligible KK samples 291/297 (98.0) 296/300 (98.7) 293/300 (97.7) 347/373 (93.0)
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On analysis of the mitochondrial CO1, B. pfeifferi was
confirmed. All eight Biomphalaria samples that were se-
quenced were 100% monomorphic. Inputting this sequence
into BLASTN 2.9.0+ showed the sequence to be 100% iden-
tical to B. pfeifferi samples from Zimbabwe (ZWE.236) with
98.1% sequence identity B. pfeifferi from Ihosy, Madagascar.
FIGURE 2. Bars representing total prevalence by CCA and Kato–Katz each year of the study, and line graph showing changes in mean EPG of
infected individuals. The 95% CI intervals of CCA and Kato–Katz prevalence values and of the mean EPG are shown by vertical error lines.
FIGURE 3. Changes in proportion of individuals with each category of infection intensity, ascertained from the Kato–Katz methodology. Black =
heavy, dark gray = moderate, light gray = light, and white = negative.
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DISCUSSION
This is, to our knowledge, the first study to describe
changes in prevalence and infection intensity of intestinal
schistosomiasis in response to ongoingMDAcontrol efforts in
Madagascar, conducted with modest resourcing and expe-
dition budgets. Over a 5-year period (following four rounds of
annual school-based MDA with PZQ, and 3 years of formal
schistosomiasis education), the prevalence by CCA assess-
ment demonstrated a small decrease in schistosomiasis
prevalence, by 5.7% (1.1–10.1%), whereas there was a re-
duction in the egg-patent infection prevalence (by KK) of
19.1% (9.0–28.1%). Despite these interventions, intestinal
schistosomiasis is still a major public health problem, with a
final prevalence of 87.7%byCCA and 59.4%byKK. Although
the decline is important and statistically significant, it will take
TABLE 2
Changes in mean EPG across the study period, stratified by location
Mean EPG Year 5 vs. Year 1 Linear regression analysis
Site Year 1 Year 2 Year 3 Year 5 Relative change* Pcr† Padj† Coeff‡ 95%CI‡ P-value‡
All sites 480.2 325.6 276.9 216.3 −55.0% < 0.0001 < 0.0001 −58.8 −82.9, -34.6 < 0.0001
Marolambo – 234.4 141.3 186.8 −20.3% 0.376 0.362 −8.2 −42.0, 25.5 0.630
Ampasimbola 641.1 284.4 248.4 96.0 −85.0% 0.036 0.089 −146.59 −247.5, -45.4 0.005
Ambohitelo 363.0 396.3 214.8 77.8 −78.6% 0.001 0.002 −74.1 −116.1, -32.3 0.001
Marofatsy 429.7 272.0 243.7 281.2 −34.6% 0.287 0.277 −58.3 −156.7, 40.1 0.124
Vohidamba 470.6 408.0 539.4 211.7 −55.0% 0.219 0.175 −47.9 −144.8, 49.0 0.330
Betampona 503.4 337.2 217.3 285.2 −43.3% 0.046 0.042 −41.2 −90.2, 7.7 0.098
P (ANOVA)§ 0.431 0.660 0.001 0.150 – – – – – –
Results from univariable andmultivariable linear regression analyses compare themeanEPG from year 5 to year 1. In addition, this table shows the change inmean EPG for each subsequent year
of the study, estimated by the linear regression analysis.
* Relative change in mean EPG comparing year 5 with year 1.
†Results from simple univariable (cr) andmultivariable linear regression (adj) analyses comparingmean EPG from2019 to baseline.Multivariable linear regression controlled for the effects of age
and gender.
‡ Linear regression coefficient and95%CI of the coefficient: results from themultivariable linear regressionmodel for change inmeanEPG for each subsequent year, adjustedby age andgender.
§Results from analysis of variance (ANOVA).
FIGURE 4. Line graphs showing theprevalence of childrenwithS.mansonibybothCCA (dotted lines) andKK (solid lines), for each village. Vertical
error lines represent the 95% CI of the prevalence values. This figure appears in color at www.ajtmh.org.
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much longer than 5 years of effective annual MDA to gain
public health control in this high-endemic and resource-poor
setting. Our observations now call for a commensurate future
response.
Nonetheless, reductions in the district-level infection in-
tensity observed aremore encouraging. Themean EPG fell by
55.0% (from 480.2 EPG at baseline to 216.2 in year 5), and the
prevalence of heavy infection intensities fell by 53.3% (from
23.7% to 10.1%). Schistosomiasis disease severity is asso-
ciated with infection intensity, where heavier infections cause
more severe disease manifestation.9,23 However, light/
moderate intensity infections also cause significant inflam-
mation, leading to pain, diarrhea, undernutrition, cognitive
impairment, and fatigue.8,24 Although prevalence ofmoderate
and light infections in year 5 was 16.1% and 33.1%, re-
spectively, these are likely to be underestimates because of
the low sensitivity of the KK diagnostic techniques for
detecting light intensity infections,25,26 and therefore, there
could be many more children burdened by schistosome-
induced morbidities which we have seen on ultrasonogra-
phy.18 Studies using refined diagnostic accuracy with novel
antigenic measures are therefore needed, with, for example,
the promising and highly sensitive, highly specific upcon-
verting particle-lateral flow-circulating anodic antigen
assay.27,28
Our study assessed the impact of MDA and schistosomia-
sis education over time in Madagascar. Other studies have
also examined the response to annual MDA elsewhere with
variable and inconsistent findings. Two studies in Kenya and
Uganda describe comparable S. mansoni KK baseline prev-
alence values among selected high-transmission zones
(73.5% and 77.2%, respectively). In Kenya, investigators ob-
servednodifferences in either prevalenceor infection intensity
following four rounds of community wide MDA,11 whereas
in the high prevalence locations of Uganda, investigators
reported a reduction in prevalence of 50.1% after only two
rounds of MDA and a reduction of infection intensity by
83.4%.29 On Kome Island, Tanzania, investigators demon-
strated a fall in KK prevalence of S. mansoni among school-
children from 42.2% to 4.0% (a 90.5% reduction) following 5
years of MDA where they also installed additional safe water
supplies.30
Persistent hotspots are locations characterized by resilient
transmission of schistosomiasis, with persistently high prev-
alence and/or disease burden despite multiple rounds of ef-
fective delivery of MDA, as demonstrated by this study.
Whether a community responds to schistosomiasis control
efforts is multifactorial; immediate reinfection with schisto-
somiasis following MDA can be influenced by socioeconomic
and water, sanitation, and hygiene (WASH) factors. These
include access to latrines, frequency of contact with con-
taminatedwaters, and availability of safe drinking water.31 For
example, in Tanzania, children with no access to drinking
water were found to have three–four times the odds of per-
sistent schistosomiasis compared with children with safe
access to drinking water,31 and a meta-analysis reported that
those with access to safe water have 47% less chance of
schistosomiasis than those without access to safe drinking
water.32 In Marolambo, between 40 and 80% of school-
children are known to have daily contact with the Nosivolo
River, and although gravitational water supplies exist, they are
prone to damage; very few exist, and thewater they carrymay
not be free from cercariae (S. A. Spencer, et al., unpublished
data).Marolambo is a farming district wheremore than 95%of
the habitants aremixed farmers, many involved in tending rice
production. Many children work in the rice paddies, pan for
gold in the Nosivolo, and use streams as alternative water
sources for washing, drinking, and bathing, noting that chil-
dren younger than school-age are also infected and at risk (S.
A. Spencer, et al., unpublished data); all are areas where
FIGURE 5. Scatterplots of EPG for each location and district total. Lines represent the linear regression plot of mean EPG with 95%CI (shaded).
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S. mansoni–infected Biomphalaria were found in this study.
The degree of daily exposure to infested waters is therefore
likely to be much higher than 40–80% in this district. En-
couraging the use of protective clothing, for example, when
farming in rice paddies, would be a good initial measure to
prevent long exposure with infected water contact sites. In
addition, the low ratio of pit latrines to pupils (two latrines
per school) and few household latrines are likely to contrib-
ute to the high rates of reinfection, and therefore persistent
schistosomiasis.33
Biosocial factors are also likely to have an important role in
whether a village responds to preventive chemotherapy.34
Socioculturally tailored, community participating schistoso-
miasis education can motivate communities to take re-
sponsibility for their own health through behavioral changes
and participation in control activities, attendance to MDAs,
and promotion of positive transmission and prevention-
related behaviors. In year 3, a SEP was enrolled in the same
six schools in Marolambo. This led to increased community
rapport with offered preventive chemotherapy witnessed by
elevated MDA attendance and latrine use which is likely to
have contributed to the reduced prevalence of S. mansoni
between years 3 and 5. Our study showed that attendance to
MDA increased from 63% to 91%, reflecting success of the
SEP. However, persistent levels of community infection may
be sustained by those children missing out on treatment.
Population migration from villages outside of the study may
have impacted on exposure to MDA, given that total district
MDA only started from year 3.
Schistosomiasis is a focal disease with heterogeneity
demonstrated at the community level.35 Although our study
showed similar levels of schistosomiasis between locations,
differences were observed in response to MDA over time.
Children in only Ambohitelo village experienced reductions in
both the prevalence of infection and infection intensity. Al-
though the largest reduction in egg-patent prevalence was
observed inMarofatsy village, therewas no significant change
in themean infection intensity. However, the small sample size
in Marofatsy in year 5 limits this analysis. Although there were
many children with extremely high outlying EPG values in
years 1–3 of the study, by year 5, nearly all outliers came from
only two villages: Betampona and Marolambo. These highly
infected children are likely to be responsible for major local
transmission of S. mansoni, which is likely to be one reason
that the smallest, albeit nonsignificant, numerical prevalence
changes across the study period were observed in these vil-
lages. High pretreatment infection intensity is also a recog-
nized risk factor for immediate r-infection following MDA,
which may be related to incomplete parasite elimination with
praziquantel.36 Both the degree of infestation of water contact
sites with the intermediate aquatic snail hosts and the preva-
lence of infected snails are also possible contributing factors
as to whether a village responds to MDA.37 Although Bio-
mphalaria snails were found in all villages, thosewith evidence
of S. mansoni infection were only found in Betampona. This
may triangulate evidence on the finding that highly infected
individuals were identified in this village and also the largely
static high prevalence among children here. The differences in
response to MDA between villages may additionally be
explained by differences in the number of human–water con-
tact sites between locations and distance of the water from
schools.33,34,37
The Bill & Melinda Gates Foundation funded Schistosomi-
asis Consortium for Operational Research and Evaluation
(SCORE) conducted seminal studies where persistent hot-
spots were defined by village, which over the study period
(following four rounds of MDA), the relative prevalence de-
clines by < 35% and/or the mean infection intensity declines
by < 50%.38 All six villages surveyed within the Marolambo
district represent persistent hotspots by this definition. This
issue is not uncommon; in theSCOREstudies,more than30%
of villages were found to be PHSs.33
Molecular analysis of B. pfeifferi from Marolambo revealed
they were 100% identical to B. pfeifferi from Zimbabwe and
98.1% similar to B. pfeifferi from Ihosy, Marolambo. These
differences in sequences between B. pfeifferi may infer sep-
arate invasions of B. pfeifferi to Madagascar in recent years.
Genetic characterization of B. pfeifferi contributes to the un-
derstanding of high-risk transmission sites, as B. pfeifferi
strains vary in their susceptibility to different strains of
S. mansoni which have entered into Madagascar from main-
land Africa.39
Because of early administration of MDA, no reliable
S.mansoniparasitological datawere collected in year 4,which
is a limitation of this study. In addition, because of the het-
erogeneity of schistosomiasis infection, findings from this
study are not generalizable to other remote districts of
Madagascar. However, there is limited access to WASH fa-
cilities inmany parts ofMadagascar.40 UNICEF anticipate that
across Madagascar, on average, two of five children defecate
outdoors, and more than 57% of people have no access to
safe drinking water.41,42 This is a particular issue in rural
Madagascar, where only 34% of children have access to safe
water.43 Children in rural regions who are also endemic with
Schistosoma are therefore likely to suffer from high-intensity
infections, and therefore, upscaling of national control efforts
is required.40
CONCLUSION
Despite 4 years of preventive chemotherapy in the Mar-
olambo district, Madagascar, intestinal schistosomiasis
remains a significant public health challenge, with a prev-
alence of 86.7%byCCA and 59.4%by KK, and 10%of SAC
have heavy infection intensities. This suggests that the
burden from schistosomiasis-associated morbidities is still
high. Managing high transmission zones where reinfection
rates are high can be challenging, as demonstrated in this
study, and gaining control with MDA will take much longer
than expected. Tackling this issue in hard-to-reach com-
munities living in poverty is necessary to achieve both the
WHO roadmap toward NTD control and elimination and UN
agenda for Universal Health Coverage, but this is not pos-
sible without sufficient external funding. Vitally, scaling up
multi-sectoral efforts is necessary to achieve schistoso-
miasis control. These efforts should be directed toward
improving WASH factors, installing points of access to safe
water, expansion of culturally tailored SEPs to motivate
communities to take responsibility for their local schisto-
somiasis control in addition to strategies for snail control.
Community-wide, reaching preschool-aged children, and/
or twice yearly MDA is also likely to be beneficial, and
its impact should be tested through robust research
methodology.
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Supplemental Table S1. Prevalence of S. mansoni infection by CCA. Unadjusted (crude) p values from chi-squared test 
compare prevalence values both within variable categories and across years. Results from the generalized linear mixed model 
(GLMM) adjusted prevalence ratios are shown.   








  GLMM: Year 5 vs Year 1 
 
% (95%CI) % (95%CI) % (95%CI) % (95%CI) pcrude§  PR (95%CI)* padj* 
Overall CCA 
prevalence (%) 
93.9 (91.0-96.1) 97.7 (95.2-99.1) 87.8 (83.5-91.3) 87.7 (83.9-90.9) <0.0001  0.943 (0.899-0.989) 0.016 
Age 
     
   
5-8 89.5 (83.0-94.1) 96.3 (92.9-99.1) 82.9 (74.8-89.2) 83.6 (76.6-89.0) 0.006  0.949 (0.867-1.041) 0.268 
9-12 95.6 (91.2-98.2) 98.4 (94.0-99.8) 90.7 (83.9-92.3) 91.2 (85.4-95.2) 0.023  0.950 (0.887-1.018) 0.147 
13-14 97.7 (91.9-99.7) 98.4 (89.9-99.9) 91.7 (81.6-97.2) 89.4 (79.3-95.6) 0.048  0.919 (0.844-1.000) 0.050 
p§ 0.023 0.495 0.113 0.117 
 
   
      
   
Gender 
     
   
Female 95.2 (91.1-97.8) 97.4 (93.2-99.3) 86.3 (79.6-91.4) 88.1 (82.6-92.4) <0.0001  0.938 (0.879-1.000) 0.049 
Male 92.7 (88.1-96.0) 98.0 (94.3-99.6) 89.3 (83.1-93.7) 87.2 (81.5-91.8) 0.004  0.951 (0.887-0.992) 0.016 
p§ 0.312 0.742 0.437 0.812 
 
   
      
   
Village 
     
   
Marolambo 86.9 (77.8-93.3) 100.0 (92.6-100.0) 79.6 (65.7-89.8) 82.2 (74.1-88.6) 0.012  0.956 (0.851-1.074) 0.451 
Ampasimbola 92.5 (83.4-97.5) 100.0 (92.9-100.0) 92.0 (80.8-97.8) 75.0 (47.6-92.7) 0.009  0.801 (0.607-1.058) 0.118 
Ambohitelo 98.5 (92.1-100.0) 94.0 (83.5-98.7) 95.8 (85.7-99.5) 98.3 (90.9-100.0) 0.464  1.001 (0.959-1.047) 0.944 
Marofatsy 100.0 (92.7-100.0) 96.0 (86.2-99.5) 85.7 (72.8-94.1) 95.7 (78.1-99.9) 0.013  0.954 (0.874-1.041) 0.291 
Vohidamba 92.3 (81.5-97.9) 98.0 (89.4-99.9) 89.8 (77.8-96.6) 72.7 (49.8-89.3) 0.008  0.770 (0.588-1.006) 0.055 
Betampona 96.1 (86.5-99.5) 98.0 (89.4-99.9) 84.0 (70.9-92.8) 90.6 (84.2-95.1) 0.045  0.952 (0.881-1.030) 0.222 
p§ 0.130 0.315 0.165 0.002 
 
   
§ Chi-squared test p values. 
* Results from generalized linear mixed model (GLMM) comparing prevalence from Year 5 to Year 1. 
  
Supplemental Table S2. Prevalence of S. mansoni infection by Kato-Katz. Unadjusted (crude) p values from chi-squared 
tests compare prevalence values both within variable categories and across years. Results from the generalized linear 
mixed model (GLMM) adjusted prevalence ratios are shown.   








 GLMM: Year 5 vs Year 1 
 




73.9 (68.4-78.8) 74.3 (69.0-79.2) 77.8 (72.6-82.4) 59.4 (54.0-64.5) <0.0001 0.809 (0.719-0.910) <0.0001 
Age 
     
  
5-8 67.7 (57.4-76.9) 70.1 (64.9-80.9) 72.0 (63.0-79.9) 51.8 (43.3-60.3) 0.002 0.809 (0.647-1.011) 0.068 
9-12 76.0 (67.7-83.0) 77.0 (65.2-81.8) 82.9 (74.8-89.2) 62.7 (54.2-70.6) 0.002 0.783 (0.660-0.930) 0.005 
13-14 78.8 (67.0-87.9) 76.2 (63.8-86.0) 79.3 (66.7-88.9) 68.8 (55.9-79.8) 0.486 0.893 (0.714-1.116) 0.318 
p§ 0.222 0.453 0.128 0.042 
 
  
      
  
Gender 
     
  
Female 73.2 (65.3-80.1) 76.2 (66.8-81.5) 75.2 (67.3-82.0) 58.4 (50.8-65.8) 0.001 0.786 (0.665-0.929) 0.005 
Male 74.7 (66.7-81.6) 72.4 (66.2-80.8) 80.4 (73.1-86.5) 60.4 (52.6-67.8) 0.001 0.839 (0.713-0.988) 0.035 
p§ 0.772 0.461 0.281 0.715 
 
  
      
  
Village 
     
  
Marolambo . 70.8 (55.9-83.0) 66.0 (50.7-79.1) 58.6 (47.5-66.7) 0.304 0.829 (0.656-1.048)** 0.118** 
Ampasimbola 72.6 (59.8-83.1) 80.0 (66.3-89.7) 81.6 (68.0-91.2) 42.9 (17.7-71.1) 0.021 0.605 (0.331-1.104) 0.102 
Ambohitelo 69.6 (57.3-80.1) 75.5 (61.1-86.7) 81.6 (68.0-91.2) 45.8 (32.7-59.2) <0.0001 0.665 (0.484-0.912) 0.012 
Marofatsy 75.0 (61.6-85.8) 61.2 (46.2-74.8) 73.5 (58.9-85.1) 35.0 (15.4-59.2) 0.006 0.461 (0.250-0.853) 0.014 
Vohidamba 77.4 (63.8-87.7) 80.0 (66.3-90.0) 87.8 (75.2-95.4) 66.7 (43.0-85.4) 0.225 0.886 (0.600-1.165) 0.291 
Betampona 76.5 (62.5-87.2) 78.0 (64.0-88.5) 76.0 (61.8-86.9) 71.3 (62.3-79.1) 0.769 0.942 (0.779-1.139) 0.537 
p§ 0.867 0.237 0.151 0.002 
 
  
§ Chi-squared test p values. 
* Results from generalized linear mixed model (GLMM) comparing prevalence from Year 5 to Year 1. 
**Comparison of Year 5 data to Year 2 due to missing values from Year 1 for Marolambo village.  
  
Supplemental Table S3. Results of generalized linear mixed model on 
schistosomiasis prevalence by year, controlling for location, age and gender.  
 
Prevalence 
n (%) PRadj 95%CIadj padj 
CCA     
Year 1 356 (93.9) ref ref ref 
Year 2 291 (97.7) 1.042 1.009-1.075 0.011 
Year 3 259 (87.8) 0.935 0.890-0.982 0.007 
Year 5 321 (87.7) 0.943 0.899-0.989 0.016 
     
KK     
Year 1 215 (73.9) ref ref ref 
Year 2 220 (74.3) 1.015 0.922-1.118 0.763 
Year 3 228 (77.8) 1.068 0.973-1.171 0.167 
Year 5 206 (59.4) 0.809 0.719-0.910 <0.0001 
     
Heavy infection      
Year 1 69 (23.7) ref ref ref 
Year 2 54 (18.2) 0.802 0.583-1.100 0.171 
Year 3 39 (13.3) 0.595 0.415-0.853 0.005 
Year 5 35 (10.1) 0.467 0.317-0.687 <0.0001 
 
  
Supplemental Figure S1. Line graphs show the prevalence of school-aged children positive for S.
mansoni by CCA (dotted lines) and KK (solid lines). Vertical error lines represent 95% confidence
intervals. a) District-wide data; b) data stratified by both village and age group.
b
a
Supplemental Figure S2. Line graphs show the changes in mean infection intensity (mean EPG
among infected school-aged children) by year. Vertical error lines represent 95% confidence
intervals. a) District-wide data; b) changes in mean EPG among each village; c) changes in mean




Supplemental Figure S3. Changes in proportion of individuals with each CCA grading.
